Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Emily Valentino"'
Autor:
Robert J. Mayer, Emily Valentino, Alexander Zukiwski, Michele Ly, Allison F. O'Neill, David Markowitz, G. Leonard, Peter T. Kingham, Ghassan K. Abou-Alfa, Alan P. Venook, Cameron Brennan, Olca Basturk, Emir Hoti, James J. Harding, Adam C. Yopp, Michael P. LaQuaglia, John D. Gordan, Muhammad Shaalan Beg, Stephen Leong, Mikaela Bradley, Ken Ren, John Crown, Rachel Kobos
Publikováno v:
Oncologist
Lessons Learned The fibrolamellar carcinoma-associated DNAJB1-PRKACA gene fusion transcript RNA codes for the catalytic domain of protein kinase A and, thus, overexpression of Aurora kinase A. ENMD-2076 showed a favorable toxicity profile. The limite
Autor:
Andrea Cercek, James J. Harding, Ahmet Zehir, Emily Valentino, Maeve A. Lowery, Imane El Dika, Joanne F. Chou, Teresa Rasalan-Ho, Mikaela Bradley, Kenneth H. Yu, Ezra Morgono, Ellen Hollywood, Michael F. Berger, Marinela Capanu, Ghassan K. Abou-Alfa, Philip C. Wong, Ryan Ptashkin, Scott R. Gerst, Erica Salehi, Eileen M. O'Reilly
Publikováno v:
Clinical Cancer Research. 25:937-945
Purpose: Mutations in the RAS/RAF/MEK/ERK signaling pathway are commonly found in biliary tract cancer (BTC). Binimetinib, a selective inhibitor of MEK1/2, has single-agent activity. Preclinical data support binimetinib combination with chemotherapy,
Autor:
Peter J. Allen, Brian R. Untch, Emily Valentino, Olca Basturk, Nitya Raj, Laura H. Tang, Marinela Capanu, David S. Klimstra, Diane Reidy-Lagunes
Publikováno v:
Pancreas. 46:296-301
Emerging data suggest that not all grade 3 (G3) pancreatic neuroendocrine neoplasms (panNENs) behave the same; tumor differentiation may predict outcome.Patients with G3 panNENs treated at our institution between 1999 and 2014 were identified. Demogr
Autor:
Khrystyna Uhlitskykh, James J. Harding, Ghassan K. Abou-Alfa, Xiaoxing Feng, Eileen M. O'Reilly, Jessica Frick, John S. Bomalaski, Richard K. G. Do, Ellen Hollywood, Casey R. Hamilton, Emily Valentino, Peter Justin Wan, Chien-Feng Li, Amanda Johnston
Publikováno v:
Journal of Clinical Oncology. 36:4085-4085
4085Background: Arginine depletion interferes with pyrimidine metabolism as well as DNA damage repair pathways, and preclinical data indicate that pairing pegylated arginine deaminase (ADI-PEG 20) ...
Autor:
James J. Harding, Emily Valentino, Ghassan K. Abou-Alfa, Marinela Capanu, Ryma Benayed, Maria E. Arcila, Imane El Dika, Leonard B. Saltz, Michael F. Berger, Eileen M. O'Reilly, Matthew Rusek
Publikováno v:
Journal of Clinical Oncology. 35:e15668-e15668
e15668 Background: FLC is a rare cancer arising in non-cirrhotic liver of young adults. A functional chimeric transcript resulting from the in-frame fusion of DNAJB1 with PRKACA genes on chromosome 19 is thought to be universal and unique in FLC. Thi
Autor:
Diane Lauren Reidy, Jaclyn F. Hechtman, Tara Soumerai, Nitya Raj, Michael F. Berger, Emily Valentino
Publikováno v:
Journal of Clinical Oncology. 34:e15661-e15661
246 Background: Whole exome sequencing in WD pNETs demonstrated an increased number of mutations in chromatin modeling genes (MEN1, DAXX, and ATRX), and in the mTOR pathway. NGS brings this technology to the clinic but its relevance in practice has b
Autor:
Scott R. Gerst, Leonard B. Saltz, Seth S. Katz, Diane Lauren Reidy, Betty Y Lung, Kelly Olino, Emily Valentino, Brian R. Untch, Nitya Raj, Vivian E. Strong
Publikováno v:
Journal of Clinical Oncology. 33:4105-4105
4105 Background: ACC is a rare but devastating disease, with short life expectancy in the setting of metastatic, unresectable disease. Mitotane, an oral adrenocorticolytic agent, is often used as a systemic treatment though its therapeutic window is
Autor:
Emily Valentino, Nitya Raj, Laura H. Tang, David S. Klimstra, Marinela Capanu, Diane Lauren Reidy, Olca Basturk
Publikováno v:
Journal of Clinical Oncology. 33:e15185-e15185
e15185 Background: World Health Organization criteria define HGNEC as neuroendocrine tumors with Ki-67 index > 20%. However, it is unknown if treatment response and/or outcomes vary based on cellul...